iKang Healthcare Group, Inc.
KANG
KANG was delisted on the 18th of January, 2019.
63 hedge funds and large institutions have $772M invested in iKang Healthcare Group, Inc. in 2018 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 22 increasing their positions, 16 reducing their positions, and 13 closing their positions.
44% more call options, than puts
Call options by funds: $2.38M | Put options by funds: $1.65M
38% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 16
37% more capital invested
Capital invested by funds: $564M → $772M (+$209M)
23% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 13
5% more funds holding
Funds holding: 60 → 63 (+3)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
Assured Investment Management
New York
|
+$129M |
| 2 |
FTCM
Fir Tree Capital Management
New York
|
+$46M |
| 3 |
Millennium Management
New York
|
+$20.2M |
| 4 |
AC
Athos Capital
Hong Kong
|
+$14.1M |
| 5 |
Man Group
London,
United Kingdom
|
+$11.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCMH
Kontiki Capital Management (HK)
Hong Kong
|
-$27.2M |
| 2 |
Fidelity International
Hamilton,
Bermuda
|
-$14.9M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$14.2M |
| 4 |
NMC
Nine Masts Capital
Central,
Hong Kong
|
-$8.17M |
| 5 |
VBA
Van Berkom & Associates
Montreal,
Quebec, Canada
|
-$2.16M |
KANG Hedge Fund Activity: Q2 2018 in Review
63 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in iKang Healthcare Group, Inc. (KANG) for Q2 2018, worth a combined $772M — up 37% from $564M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new KANG positions and 13 closed out — a net gain of 3 holders — while 22 added to existing stakes and 16 trimmed.
The largest buyer was Assured Investment Management, opening a new position worth an estimated $129M. The largest seller was Kontiki Capital Management (HK), exiting entirely with an estimated $27.2M sold.
- 63 institutional investors held iKang Healthcare Group, Inc. (KANG) as of Q2 2018, up from 60 in Q1 2018.
- Funds reported $772M of iKang Healthcare Group, Inc. stock for Q2 2018, up 37% quarter-over-quarter.
- 16 funds opened new iKang Healthcare Group, Inc. positions in Q2 2018 and 13 closed out, a net change of +3 holders.
- The largest iKang Healthcare Group, Inc. buyer in Q2 2018 was Assured Investment Management, an estimated $129M added.
- The largest iKang Healthcare Group, Inc. seller in Q2 2018 was Kontiki Capital Management (HK), an estimated $27.2M sold.
Based on aggregated 13F filings for Q2 2018.